Guest guest Posted August 31, 2002 Report Share Posted August 31, 2002 Pam: Thanks for the info. someone posted s reference to this study earlier with only a phone number. I have called Dr. S twice and spoken to his secretary about getting this info made available. Dr. S was supposed to get back tome; have not heard back as yet. Your info does not indicate clearly which symptoms they feel might be affected. Also, I suspect travel to Cleveland would be required. Message: 10 Date: Fri, 30 Aug 2002 18:57:57 -0300 Subject: RESEARCH STUDY: Hytrin Opportunity for Patients with Multiple System Atrophy The Cleveland Clinic Foundation is beginning a study investigating the effects of the drug Hytrin (Terazosin) on improving the symptoms commonly associated with Multiple System Atrophy. Hytrin is a commonly used, FDA-approved medication used in the treatment of Benign Prostatic Hypertrophy (BPH) (to relieve urinary retention) and Hypertension (to lower blood pressure). Patients interested in participating would undergo a neurological and physical evaluation including questionnaires and timed motor tests. Subjects are then randomized, like a flip of a coin, to either Hytrin or a placebo for several weeks and undergo a series of neurological and physical evaluations. Neither you nor your doctor will know if you are on the study medication. Every one or two weeks for 12 weeks (end of study), subjects will undergo further neurological evaluations. For more information, contact Ruthie Kolb, at or Dr. Thyagarajan Subramanian at . Sennewald Charlottesville, Virginia Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 31, 2002 Report Share Posted August 31, 2002 FYI ... that info I posted came directly from Dr. Subramanian. Take care, Pam RESEARCH STUDY: Hytrin > > > Opportunity for Patients with Multiple System Atrophy > > > The Cleveland Clinic Foundation is beginning a study investigating the > effects of the drug Hytrin (Terazosin) on improving the symptoms commonly > associated with Multiple System Atrophy. Hytrin is a commonly used, > FDA-approved medication used in the treatment of Benign Prostatic > Hypertrophy (BPH) (to relieve urinary retention) and Hypertension (to lower > blood pressure). Patients interested in participating would undergo a > neurological and physical evaluation including questionnaires and timed > motor tests. Subjects are then randomized, like a flip of a coin, to either > Hytrin or a placebo for several weeks and undergo a series of neurological > and physical evaluations. Neither you nor your doctor will know if you are > on the study medication. Every one or two weeks for 12 weeks (end of > study), subjects will undergo further neurological evaluations. > > > For more information, contact Ruthie Kolb, at or Dr. > Thyagarajan Subramanian at . > > > Sennewald Charlottesville, Virginia Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.